NKTX

Nkarta, Inc.

NasdaqGSUSDEQUITY DELAYED

2.61

▲ 0.14 (5.67%)

MARKET · —

Price

Open

2.54

Prev close

2.47

Day high

2.74

Day low

2.48

Volume

1.09M

Market cap

—

P/E (TTM)

—

52W range

1.70 – 3.72

Trailing performance

Price return · vs SPY

Returnvs SPY

+14.16% +15.5%

+15.65% +11.9%

-12.21% -15.3%

+14.16% +3.1%

YTD

+43.78% +31.5%

+17.70% -2.3%

+35.71% -38.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

2.43

+7.32% from price

SMA 20

2.32

+14.46% from price

SMA 50

2.62

+1.53% from price

SMA 100

2.71

-3.76% from price

SMA 200

2.40

+10.97% from price

EMA 12

2.44

+7.01% from price

EMA 26

2.45

+6.35% from price

EMA 50

2.54

+2.74% from price

RSI (14)

58.5

Neutral

MACD (12,26,9)

-0.02

Hist 0.06

ATR (14)

0.16

5.97% of price

Realised vol 30D

59.1%

Annualised

Bollinger upper

2.61

20, 2σ

Bollinger lower

2.03

20, 2σ

50 / 200 cross

Golden

2.62 vs 2.40

Trend bias

Above 200

+10.97%

Risk profile

Daily returns · 1Y window

Beta vs SPY

2.01

More volatile than market

Correlation to SPY

0.35

Loosely linked

Realised vol 30D

59.1%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-43.1%

Peak to trough

Max drawdown 5Y

-96.1%

Peak to trough

ATR 14

0.16

5.97% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 2.61

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

NKTX · links out to the publisher

Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights GlobeNewswire · 12d ago Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development GlobeNewswire · 30d ago Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference GlobeNewswire · 57d ago TD Cowen Initiates Nkarta at Buy MT Newswires · 60d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.